STERIS Share Repurchase Authorization Limit decreased by 25.0% to $150.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $300.00M to $150.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher limits suggest strong cash flow and management's belief that the stock is undervalued.
This is the maximum dollar value or share count authorized by the Board of Directors for the repurchase of the company's...
Common among mature, cash-generative companies seeking to optimize their capital structure.
share_repurchase_authorization_limit| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $333.93M | $333.93M | $333.93M | $294.65M | $249.37M | $160.63M | $500.00M | $443.88M | $400.00M | $300.00M | $300.00M | $200.00M | $150.00M |
| QoQ Change | — | +0.0% | +0.0% | -11.8% | -15.4% | -35.6% | +211.3% | -11.2% | -9.9% | -25.0% | +0.0% | -33.3% | -25.0% |
| YoY Change | — | — | — | -11.8% | -25.3% | -51.9% | +69.7% | -11.2% | — | — | -32.4% | -50.0% | -50.0% |